UK-EU SPS Deal Could Replace GB-Only Novel Food Approvals
UK-EU SPS alignment would replace GB novel food approvals with EU authorizations, changing the payoff from a British launch for American food innovators. Approval-linked GB exclusivity would also cease under the planned agreement.
Primary lensTrade policy
Sub-topicPolicy monitoring
Evidence base8 records used
Use casePolicy monitoring
Great Britain's food regulators published guidance on September 30 explaining how cell-cultivated food businesses can obtain a domestic market authorization. Two weeks earlier, the Food Standards Agency told its Board that the planned UK-EU sanitary and phytosanitary agreement would end GB authorizations when it takes effect, subject to very limited exceptions. The domestic application route remains open while the government negotiates its replacement. , .
For the regulatory lead at a U.S. innovative food producer, that changes the investment case for a British launch. A GB approval may still support sales under today's rules. It cannot be assumed to sustain those sales after alignment, or to preserve the exclusive market position attached to protected application data. The GB launch file needs to identify how long the business can use that approval and what permission would support continued sales.
US-UK Trade Terms Leave the Food Rules in Place
The US-UK Economic Prosperity Deal does not resolve that question. Paragraph 2(a) of its general terms says imported food and agricultural goods must meet the importing country's SPS standards and other mutually agreed standards. The document also expressly identifies itself as non-binding. Commitments to improve agricultural market access therefore provide no product-specific promise that a British authorization will survive a change in British rules. US-UK Economic Prosperity Deal general terms.
Defra's preparation guidance says alignment will affect businesses even when they do no direct EU trade. A U.S. producer supplying only Great Britain would therefore face the proposed authorization change through its destination market. The relevant commercial exposure is the product's permission to remain on sale in England, Scotland and Wales. Defra food manufacturing preparation guidance.
A GB Approval Has an Unsettled Commercial Life
Under the current system, a novel food must be authorized before it enters the GB market. The FSA register records permitted products and their terms. An authorization is usable within those conditions, with additional restrictions where protected data are involved. A pending application supplies none of that permission. FSA novel food authorization guidance.
The September Board paper says the FSA and Food Standards Scotland's Market Authorisation Service has about 390 applications and takes more than two years on average to reach authorization. That average covers the service's caseload, rather than promising a timetable for a particular novel food. The agency is preparing for summer 2027 implementation, while the final agreement and implementation arrangements remain unresolved. FSA September SPS paper, paragraphs 5.8 and 5.16.
The commercial inference is narrower than a recommendation to abandon every GB application. A late-stage approval could still enable useful sales before alignment. The same expenditure may be harder to justify for a new application whose value depends on several years of GB-only access. The investment file should distinguish revenue achievable before a change from revenue dependent on an EU authorization or a negotiated exception. Summer 2027 belongs in a planning scenario, not as a settled legal expiry date.
Audit the Product, Then the Authorization
EU approval is not a category-wide clearance. Article 6 of the EU Novel Food Regulation ties lawful marketing to inclusion in the Union list and the applicable conditions of use and labeling. The Commission says the resulting entry can also specify product characteristics and monitoring requirements. A familiar ingredient name alone cannot establish that a U.S. producer's formulation and intended use fit an existing approval. EU Novel Food Regulation, Article 6, European Commission novel food authorization scope.
This commercial planning matrix applies those rules to the proposed alignment. It is an analytical guide, not a regulatory determination for any product.
Position in the launch file
Exposure under planned alignment
Decision before further spending
GB approval and usable EU listing
Continuity depends on the EU specification, uses and access conditions
Reconcile the sold product with the EU entry
GB approval only
Domestic permission would cease unless an agreed exception covers it
Cost the EU route and the period of GB sales
Usable EU listing, no GB approval
Alignment could create a GB route, but current GB requirements still apply
Verify present permission before launching
Applications pending in either market
Filing alone provides no marketing permission
Tie launch commitments to an actual authorization
One possible bridge would let businesses use EU-authorized products in GB before the wider agreement takes effect. The September paper asks the Board to support exploring that option. It also says legislation would be required. A producer with a usable EU listing should keep that possibility in view without treating it as present permission. FSA September SPS paper, paragraphs 5.5 to 5.7.
Protected Data Change the Payback Calculation
Defra identifies a consequence beyond product withdrawal. Under the planned agreement, GB novel food authorizations would cease along with their linked data-protection periods and associated market exclusivity. A business should therefore test an investment case that recovers application costs from protected GB sales against the proposed change. The guidance addresses those authorization-linked protections. It does not say patents, trade secrets or private licensing contracts disappear. Defra guidance on novel food authorizations.
EU rights require their own examination. Articles 26 and 27 provide five-year protection for qualifying new proprietary evidence, on request and subject to specified conditions. During protection, the listed applicant alone can market the food unless another applicant obtains authorization through independently supported evidence or the initial applicant's agreement. An EU listing might therefore solve product eligibility while leaving a particular producer without access to it. EU Novel Food Regulation, Articles 26 and 27.
That creates two different spending decisions. The holder of a GB-only protected approval needs to assess the remaining return on that approval. A producer looking to another firm's EU listing needs to establish whether it can lawfully use the listing, obtain consent or support a separate application. Neither question is answered by the strength of bilateral trade relations.
EU Preparation Starts Before the Next Study
Moving toward an EU dossier also changes decisions made before submission. EFSA's current procedure requires notification before the start of covered supporting studies commissioned or carried out after March 27, 2021. Its guidance provides clarification on which studies require notification. A producer commissioning more evidence for a GB application should check that scope before work begins if it expects to use the evidence in an EU submission. EFSA novel food pre-submission procedure.
The Commission's authorization process requires an adopted implementing act and an updated Union list before the food can be marketed. A favorable scientific opinion is an intermediate step. Budget and launch commitments should reflect the remaining decision by the Commission and member states. European Commission novel food application procedure.
Revisit the launch file when the final agreement identifies the authorization rules and exceptions, implementing legislation establishes the transition, or the product obtains a usable EU listing. Preserve the GB dossier's scientific work and check new studies against the EU procedure before commissioning them.
From reading to review
Run the numbers on your lane.
The duty calculator runs the current stack for any HTS code and origin. A free account opens full tool output, AD/CVD detail, Chapter 98 processing, and available exports.